Nikola Čuřík

Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

2016 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine

Publication